Nucleus Equity Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 7.10%
- Profit Growth 16.49%
- Ebitda 254.47%
- Net Worth 13.13%
- Total Assets 0.77%
About Nucleus Equity
Nucleus Equity Private Limited (NEPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 May 1997 and has a history of 27 years and eight months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Sharma and Rajiv Sharma serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U64120WB1997PTC084209
- Company No.
084209
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 May 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
What products or services does Nucleus Equity Private Limited offer?
Nucleus Equity Private Limited offers a wide range of products and services, including Tea & Coffee, Herbal Tea, Black Tea, Flavored Tea, Tea, Fancy Cups, Tea Cups, CTC Tea, Double Wall Cup, Teapot, Coffee Mugs & Tea Sets.
Who are the key members and board of directors at Nucleus Equity?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rakesh Sharma | Director | 05-May-1997 | Current |
Rajiv Sharma | Director | 05-May-1997 | Current |
Financial Performance of Nucleus Equity.
Nucleus Equity Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.1% increase. The company also saw a substantial improvement in profitability, with a 16.49% increase in profit. The company's net worth Soared by an impressive increase of 13.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nucleus Equity?
In 2021, Nucleus Equity had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nucleus Equity?
Unlock and access historical data on people associated with Nucleus Equity, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nucleus Equity, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nucleus Equity's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.